People
-
News
WHO launches global strategic plan to fight rising Aedes-borne arboviral diseases
The World Health Organization (WHO) has launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP) to tackle dengue and other Aedes-borne arboviruses.
-
News
NSF to invest $5 million to Biofoundries project
The U.S. National Science Foundation and partner agencies in the U.S., Canada, Finland, Japan, the Republic of Korea (ROK), and the United Kingdom have announced funding awards in their Global Centers competition. One of the centers, the Reliable and Scalable Biofoundries for Biomanufacturing and Global Bioeconomy, includes researchers from the ...
-
News
Centre for Microbial Interactions at Norwich Research Park is launched
The Centre for Microbial Interactions at Norwich Research Park is launched to promote and support ground-breaking research by one of world’s largest communities of microbiologists, with more than 100 microbiology research groups on one site.
-
News
Marburg virus disease reaches Rwanda for first time with 26 confirmed cases
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedical Center and were positive for Marburg virus. ...
-
News
$12 million grant to research how vaccines induce lasting immunity
Researchers have received a $12 million grant to study how vaccines trigger long-lasting immune responses. The work may inform the design of new, more protective vaccines for respiratory viruses, including SARS-CoV-2 and influenza.
-
News
Swedish research on antibiotic pollution becomes UN declaration after 17 years
In 2007, researchers at the University of Gothenburg, Sweden published the first in a series of studies showing massive pollution with antibiotics from pharmaceutical factories in India. In connection with the ongoing UN General Assembly in New York, a declaration was approved that underlines the risks and calls for measures ...
-
News
World leaders commit to decisive action on antimicrobial resistance
Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), pledging to cut the estimated 4.95 million human deaths associated with bacterial AMR annually by 10% by 2030.
-
News
Thousands of donkeys vaccinated against rabies
The Donkey Sanctuary is collaborating with local government agencies and partner organisations, to support vaccination programmes in two key communities that rely on donkeys for their livelihoods.
-
News
European capacity for antibiotic R&D requires long-term funding
The AMR Accelerator projects have called for long-term investments, stressing the need to preserve the European capacity for antibiotic R&D by sustaining the assets, expertise, and research infrastructures required to develop new treatments for drug-resistant infections.
-
News
Eradivir closes $10.25M Series A funding round for next stage of influenza therapeutic trials
Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round which will be used to conduct a Phase 2a challenge study of its EV25 influenza treatment.
-
News
Fleming Initiative raises first £100m in the global fight against AMR
Three new partners have pledged additional funding and resources to the Fleming Initiative’s global effort to combat antimicrobial resistance (AMR), as leading medical expert Professor Lord Ara Darzi calls for tighter restrictions on the use of antibiotics.
-
News
Scientist studying parasite-derived vesicles in babesia virulence and vaccine development
Fatah Kashanchi, Professor of Virology at George Mason University, has received funding for the study: ’Parasite-Derived Vesicles in Babesia virulence and Vaccine Development’.
-
News
Researchers awarded $3 million grant to explore gut health
A $3 million grant has been awarded to investigate the energy generating processes of gut Bacteroides and how they impact our well-being.
-
News
Jordan becomes first country to receive WHO verification for eliminating leprosy
The World Health Organization (WHO) has congratulated the Hashemite Kingdom of Jordan for becoming the first country in the world to be officially verified as having eliminated leprosy.
-
News
Call for urgent, high-level action to address global scourge of antimicrobial resistance
The World Health Organization (WHO) and partners will call on world leaders to address critical global health challenges throughout the high-level week of the 79th session of the United Nations General Assembly (UNGA79).
-
News
Researchers push ambitious 1–10–100 unifying goals on antimicrobial resistance ahead of crucial UN meeting
Researchers have shared their goals of using a One Health-approach to save 10 million lives and aim for 100 per cent sustainable access to effective antimicrobials in a new policy paper ahead of a UN high-level meeting in New York later this month.
-
News
Scientists team up to track gut-brain connection in athletes with concussion
120 athletes are to take part in a concussion study with researchers to identify reliable and novel concussion biomarkers in their gut microbiomes in ways that standard brain imaging cannot.
-
News
Call for global gender-neutral HPV vaccination by 2030
A new global initiative is calling for a more ambitious, ethical and equitable approach that will see more boys and men gain access to cancer-preventing Human Papillomavirus (HPV) vaccination and protect more people worldwide from HPV-related cancers.
-
News
Large-scale study will seek to unearth causes of persistent symptoms of Lyme disease
Researchers have received $20.7 million grant to try to answer some of the most vexing questions around chronic Lyme disease, following patients from their earliest diagnosis to find out why some go on to develop debilitating symptoms later on.
-
News
NIH releases mpox research agenda
National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has released an update on its priorities for mpox research, which focus on four key objectives.